<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>UNLABELLED: Sildenafil <z:chebi fb="2" ids="50744">citrate</z:chebi> has shown to display beneficial cardiovascular effects, suggesting that it may have other systemic benefits involving the endothelium </plain></SENT>
<SENT sid="1" pm="."><plain>There is little data regarding the long-term use of this drug and the effects of this on different organs </plain></SENT>
<SENT sid="2" pm="."><plain>OBJECTIVE: The primary aim of this study was to determine whether sildenafil <z:chebi fb="2" ids="50744">citrate</z:chebi> diminishes concentrations of <z:mp ids='MP_0002959'>microalbuminuria</z:mp> and percentage of A1c in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>DESIGN: A double-blind, randomized, controlled trial in 40 male patients, age 35-50, with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>Subjects received sildenafil <z:chebi fb="2" ids="50744">citrate</z:chebi> 50 mg daily (n=20) or placebo (n=20) for 30 days </plain></SENT>
<SENT sid="5" pm="."><plain>Levels of hs-CRP, <z:mp ids='MP_0002959'>microalbuminuria</z:mp>, <z:chebi fb="0" ids="17230">homocysteine</z:chebi>, A1c and erectile function were measured at baseline and to the end of the study </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Men that received sildenafil <z:chebi fb="2" ids="50744">citrate</z:chebi> displayed a significant decrease in the <z:mp ids='MP_0002959'>microalbuminuria</z:mp> concentrations (p&lt;0.01) versus baseline, (p=0.02) versus placebo and A1c (p&lt;0.01) versus baseline, (p=0.01) versus placebo </plain></SENT>
<SENT sid="7" pm="."><plain>In addition, we observed a significant increase in the total IIEF score after 30 days of treatment (p&lt;0.01) versus baseline, (p&lt;0.01) versus placebo </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: The administration of 50mg of sildenafil <z:chebi fb="2" ids="50744">citrate</z:chebi> for 30 consecutive days diminishes <z:mp ids='MP_0002959'>microalbuminuria</z:mp> and the percentage of A1c in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>